Jodell Rae Petit, APSW, CSAC, ICS | |
13380 W Trepania Rd, Hayward, WI 54843-2186 | |
(715) 638-5102 | |
(715) 634-6107 |
Full Name | Jodell Rae Petit |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 13380 W Trepania Rd, Hayward, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386881522 | NPI | - | NPPES |
1386881522 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 128733-121 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jodell Rae Petit, APSW, CSAC, ICS 13380 W Trepania Rd, Hayward, WI 54843-2186 Ph: (715) 638-5102 | Jodell Rae Petit, APSW, CSAC, ICS 13380 W Trepania Rd, Hayward, WI 54843-2186 Ph: (715) 638-5102 |
News Archive
In view of the spread of coronavirus (COVID-19), and the stipulation from the Spanish Healthcare Ministry that Spanish healthcare workers should not attend national or international conferences, the organisers of the 12th European Breast Cancer Conference (EBCC-12) have taken the decision to postpone the conference, which was due to start on Wednesday 18 March in Barcelona, Spain.
Baxter International Inc. today announced data featuring ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], a leading recombinant treatment available worldwide, during the 24th Annual Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Amsterdam, The Netherlands.
Think about the confused feelings that occur when you meet someone whose tone of voice doesn't seem to quite fit with his or her gender.
VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.
Allos Therapeutics, Inc. today announced that results from the Phase 2b investigational trial of FOLOTYN (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) will be presented at the 35th European Society of Medical Oncology (ESMO) Congress
› Verified 6 days ago
Julie Glynn, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10752 Beal Ave, Hayward, WI 54843 Phone: 715-634-0222 Fax: 715-634-1722 | |
Holly Gray Schuck, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 13380 W Trepania Rd, Hayward, WI 54843 Phone: 715-638-5100 Fax: 715-634-6107 | |
James Brian Newman, MS, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10045 N State Road 27, Hayward, WI 54843 Phone: 715-634-0222 Fax: 715-634-1722 | |
Constance M Newman, MS, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15655 W County Road B, Hayward, WI 54843 Phone: 715-634-0607 Fax: 715-634-0617 | |
Savannah Christine Rigert, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10752 Beal Ave, Hayward, WI 54843 Phone: 715-634-0222 | |
Caitlan Myren, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10752 Beal Ave, Hayward, WI 54843 Phone: 715-634-0222 |